Arzneimittel-Forschung
1994-02-01
Nefiracetam, a novel cognition-enhancing agent. An introductory overview.
M Tanaka, K Takasuna, S Takayama
Index: Arzneimittelforschung 44(2A) , 193-4, (1994)
Full Text: HTML
Abstract
Related Articles:
Investigation on urinary proteins and renal mRNA expression in canine renal papillary necrosis induced by nefiracetam.
2005-09-01
[Arch. Toxicol. 79(9) , 500-7, (2005)]
Nefiracetam and galantamine modulation of excitatory and inhibitory synaptic transmission via stimulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons.
2009-05-05
[Neuroscience 160(2) , 484-91, (2009)]
Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
2005-06-01
[Epilepsia 46(6) , 811-8, (2005)]
Negative regulation of opioid receptor-G protein-Ca2+ channel pathway by the nootropic nefiracetam.
2004-10-01
[Ann. N. Y. Acad. Sci. 1025 , 389-97, (2004)]
Effects of Nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats.
2005-10-01
[Epilepsia 46(10) , 1561-8, (2005)]